Subtype
Ovarian Sertoli-Leydig Cell Tumor
CI-CAN-00008180Explore in graph →
Non-malignant1 active trials7 evidence items
Loading cancer entity…
Subtype
CI-CAN-00008180Explore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01247597 | DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study | recruiting | — | 1,500 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT06638931 | Agnostic Therapy in Rare Solid Tumors(ANTARES) | recruiting | Phase 2 | 28 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT03382158 | International PPB/DICER1 Registry | recruiting | — | 3,400 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome(PPB) | completed | — |
Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials
| 1,247 |
| Ashley HillOTHER |
| 1 |
| Mar 1, 2023 |
| clinicaltrials |
| NCT01042522 | Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors | unknown | Phase 2 | 63 | GOG FoundationNETWORK | 1 | Jan 25, 2022 | clinicaltrials |
| NCT00006227 | Paclitaxel in Treating Patients With Ovarian Stromal Cancer | completed | Phase 2 | 31 | Gynecologic Oncology GroupNETWORK | 2 | Mar 5, 2020 | clinicaltrials |
| NCT00748657 | Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |